BioSpace News Archive

Dicerna™ Pharmaceuticals, Inc. announced that the Compensation Committee of the Company’s Board of Directors approved inducement grants of stock options to purchase a total of 152,400 shares of common stock and 43,600 restricted stock units to be distributed among 13 new employees, with a grant date of March 2, 2020.

The Washington Poison Center is pleased to announce the winner of its 14th annual Poison Prevention Poster Contest: Vivian Vuong, a 4th grade student at Shorewood Elementary in Burien, Washington.

Northwell Health Labs announced it expects to begin testing for the coronavirus within a week, now that the US Food & Drug Administration has given the green light for outside labs to conduct the COVID-19 tests once appropriately validated.

Pancreatic Cancer Action Network and Perthera Study in Lancet Oncology Underscores the Urgent Need for Every Pancreatic Cancer Patient to Get Tested Through a Molecular Profiling Platform

UroGen Pharma Ltd. (Nasdaq:URGN) today announced financial results for the fourth quarter and full year ended December 31, 2019.

Gamida Cell Ltd. (Nasdaq: GMDA),will be presented during an oral session at the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), which is being held March 22 through March 25, 2020, in Madrid, Spain.

Saki Corporation, an innovator in the field of automated optical and X-ray inspection equipment, announces the opening of Saki’s new manufacturing plant in Yamato Koriyama City, Nara Prefecture for the manufacture of 3D automated X-ray inspection equipment to meet the increased demand for X-ray inspection in the Smart Factory.

Proscia ® and UCSF Partner to Deliver Artificial Intelligence Applications That Improve the Accuracy and Speed of Cancer Diagnosis

Ophirex, Inc., a public-benefit biotechnology company working to improve outcomes for global victims of snakebite, announced today that it has received a $2.5 million award from the Wellcome Trust’s £80 million (approximately $100 million) commitment to improve treatment of snakebite

OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it will attend the 6 th Annual International Children’s Spine Symposium (ICSS), which will take place March 13-14, 2020 in Orlando, Florida.